Influence of Type 1 Diabetes (T1DM) Treatment Type on Mental Workload
CHAM&DIAB
Influence du Type de Traitement du diabète de Type 1 (DT1) Sur la Charge Mentale Des Adolescents Avec un DT1 et Des Parents Ayant un Enfant Avec DT1.
1 other identifier
observational
800
1 country
1
Brief Summary
Influence of the type of treatment for type 1 diabetes (pump versus multiple injections versus closed loop) on the treatment burden of children and adolescents and their parents.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 23, 2023
CompletedFirst Posted
Study publicly available on registry
December 11, 2023
CompletedStudy Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2024
CompletedDecember 11, 2023
December 1, 2023
5 months
November 23, 2023
December 8, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary outcome corresponds to the score obtained after completing the study questionnaire. The questionnaire is completed at the participation agreement.
The primary outcome is the treatment burden according to the treatment modality (semi-closed loop versus insulin pump versus multi-injection) assessed using a specific questionnaire
1 day
Interventions
"Children over the age of 8 with type 1 diabetes diagnosed more than 6 months ago in France, followed in one of the hospitals that are members of the Aide aux Jeunes Diabétiques (AJD) association. Parents or people involved in the day-to-day life of children with type 1 diabetes diagnosed at least 6 months ago, whose child is being followed in France in one of the hospitals affiliated to the AJD association."
Eligibility Criteria
Patients will be recruited from the national network of the Association d'Aide aux Jeunes Diabetiques (AJD). The AJD federates local patient associations, which are regularly asked to distribute questionnaires to their members.
You may qualify if:
- Children over the age of 8 whose type 1 diabetes has been diagnosed for at least 6 months
- Parents or people involved in the day-to-day life of children with type 1 diabetes who have been diagnosed for at least 6 months
You may not qualify if:
- Parents not involved in managing their child's type 1 diabetes (child in care)
- Have already completed the questionnaire (one questionnaire completed per child and their parents or family caregivers)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Emmanuelle LABARRE
Angers, 49000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Emmanuelle LABARRE
Angers University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 23, 2023
First Posted
December 11, 2023
Study Start
January 1, 2024
Primary Completion
June 1, 2024
Study Completion
September 1, 2024
Last Updated
December 11, 2023
Record last verified: 2023-12